For Which Cancer Types Should I Avoid Agaricus Mushroom Supplement?

Highlights

Nutritional supplements and extracts like Agaricus Mushroom have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Agaricus Mushroom supplement and why should not take them?

Is it okay to take Agaricus Mushroom extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.

A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.

To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.

Taking Agaricus Mushroom extracts or nutritional supplements may benefit Primary Erdheim Chester Disease patients on Vemurafenib treatment over Soy Bean nutritional supplements. But Agaricus Mushroom supplements or Agaricus Mushroom extracts offer less benefit if on Radiation treatment for Primary Sclerosing Epithelioid Fibrosarcoma compared to Bergamot. Similarly, taking nutritional supplements Agaricus Mushroom may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene FLT3 over Evodia. But avoid nutritional supplements Agaricus Mushroom when at genetic risk of cancer due to mutation of gene VHL.

The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Agaricus Mushroom beneficial and should not be taken? Why should Agaricus Mushroom be not taken? Who should not take Agaricus Mushroom? What are side effects of Agaricus Mushroom with Radiation chemotherapy? What are the benefits of Agaricus Mushroom for cancer? Can Agaricus Mushroom help fight cancer and so on.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

Brief Overview

Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.

These are some example questions which nutrition planning should help answer for you. Should you take supplements Agaricus Mushroom? Should you take it when at genetic risk of cancer for mutation of gene FLT3? Should you take it when at genetic risk of cancer for mutation of gene VHL? Should you take it when diagnosed with Primary Sclerosing Epithelioid Fibrosarcoma? Should you take it when diagnosed with Primary Erdheim Chester Disease? Should you take it when on Vemurafenib treatment? Should you continue taking it if you change your treatment from Vemurafenib to Radiation? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Agaricus Mushroom extracts and nutritional supplements.

Cancer

Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Erdheim Chester Disease or Primary Sclerosing Epithelioid Fibrosarcoma, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Agaricus Mushroom.

So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Agaricus Mushroom extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene FLT3 the same as due to mutation of gene VHL? Are the implications of Primary Erdheim Chester Disease the same as Primary Sclerosing Epithelioid Fibrosarcoma? Is it one and the same if you are on treatment with Radiation or Vemurafenib?

Agaricus Mushroom – An Extract or Nutritional Supplement

Agaricus blazei Murill, commonly known as Agaricus Mushroom or Agaricus blazei is an edible mushroom native to Brazil, but is also grown in China, Japan and the United States. It is considered to have antioxidant, anti-inflammatory and antimicrobial effects. Following are some of the purported uses/potential health benefits of Agaricus Mushrooms:

• May help reduce insulin resistance in Type 2 diabetes (Chung-Hua Hsu et al, J Altern Complement Med., Jan-Feb 2007)
• May help reduce Inflammatory Bowel Disease (D T Førland et al, Scand J Immunol., 2011)
• May help improve liver health (Chung-Hua Hsu et al, J Altern Complement Med., 2008)

Agaricus Mushroom supplements contain many active ingredients including Vitamin E, Ergosterol, Vitamin B3, Vitamin C and Linoleic Acid at different concentration levels. The molecular pathways which are regulated by Agaricus Mushroom include MAPK Signaling, TGFB Signaling, Angiogenesis and PI3K-AKT-MTOR Signaling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Agaricus Mushroom individually or in combination is an important decision to be made. When making decisions on the use of supplement Agaricus Mushroom over other nutritional supplements – do consider all these factors.

Who Should not take Agaricus Mushroom Supplements and Why?

There is no easy way to answer the question “For which cancers should I not chooseAgaricus Mushroom nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Agaricus Mushroom in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Agaricus Mushroom should be avoided or not and why.

1. Will Agaricus Mushroom Supplements benefit Primary Sclerosing Epithelioid Fibrosarcoma patients undergoing Radiation treatment?

Primary Sclerosing Epithelioid Fibrosarcoma is characterized and driven by specific genetic mutations like PBRM1, ATRX and PIK3C2G leading to biochemical pathway changes in TGFB Signaling and Inositol Phosphate Signaling. A cancer treatment like Radiation works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Agaricus Mushroom supplement should not be taken for Primary Sclerosing Epithelioid Fibrosarcoma along with treatment Radiation. Agaricus Mushroom supplement impacts the biochemical pathway called TGFB Signaling which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any

2. Will Agaricus Mushroom Supplements benefit Primary Erdheim Chester Disease Patients undergoing Vemurafenib Treatment?

Primary Erdheim Chester Disease is characterized and driven by specific genetic mutations like MAP2K1, ARAF and ARID5B leading to biochemical pathway changes in Angiogenesis, RAS-RAF Signaling, MAPK Signaling and Suppressive Histone Methylation. A cancer treatment like Vemurafenib works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Agaricus Mushroom supplements should be considered for Primary Erdheim Chester Disease along with the treatment Vemurafenib. Agaricus Mushroom supplement impacts pathways/processes like MAPK Signaling which either obstruct drivers of Primary Erdheim Chester Disease and/or improve Vemurafenib treatment effect.

3. What about Agaricus Mushroom Supplements for Healthy Individuals with VHL Mutation associated Genetic Risk?

Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. VHL is one of the genes generally available in panels for cancer risk testing.

VHL mutation causes biochemical pathways/processes like Angiogenesis and Hypoxia to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Agaricus Mushroom should not be taken when the genetic panel identifies mutation of VHL for Kidney Cancer. Agaricus Mushroom impacts pathways/processes like Angiogenesis and creates adverse conditions with VHL.

4. What about Agaricus Mushroom Supplements for Healthy Individuals with FLT3 Mutation associated Genetic Risk?

FLT3 is one of the genes available in panels for cancer risk testing. FLT3 mutation causes biochemical pathways/processes like JAK-STAT Signaling, MAPK Signaling and PI3K-AKT-MTOR Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Agaricus Mushroom supplements may be considered when the genetic panel identifies mutations in FLT3 for Acute Myeloid Leukemia. Agaricus Mushroom impacts pathways/processes like PI3K-AKT-MTOR Signaling and creates a canceling effect in those individuals with FLT3 mutation.

* Other Factors are also included like BMI, Treatments, Lifestyle Habits

In Conclusion

It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Agaricus Mushroom are chosen by you and can influence outcomes.

“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.

The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.

What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.

The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.

Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.

References

• Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.
• Reactive oxygen species-mediated breast cell carcinogenesis enhanced by multiple carcinogens and intervened by dietary ergosterol and mimosine.
• Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1.
• Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons.
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
• Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.
• cBioPortal for Cancer Genomics
• Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells.